Tomoya Muto
Overview
Explore the profile of Tomoya Muto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
549
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakao S, Tsukamoto S, Takeda Y, Ohwada C, Ri C, Izumi S, et al.
Int J Hematol
. 2024 Aug;
120(4):501-511.
PMID: 39190255
Criteria for airflow obstruction (AFO) at one year after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in pulmonary function tests (PFTs) are more stringent than the bronchiolitis obliterans syndrome (BOS) criteria...
2.
Ishii A, Tsukamoto S, Mimura N, Miyamoto-Nagai Y, Isshiki Y, Matsui S, et al.
Sci Rep
. 2024 May;
14(1):10362.
PMID: 38710832
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein [M-protein], and skin changes) is a rare systemic disorder characterized by various symptoms caused by underlying plasma cell (PC) dyscrasia. Detection of monoclonal...
3.
Matsui S, Ri C, Bolanos L, Choi K, Shibamiya A, Ishii A, et al.
Leukemia
. 2024 Apr;
38(5):1032-1045.
PMID: 38609495
TNF receptor associated factor 6 (TRAF6) is an E3 ubiquitin ligase that has been implicated in myeloid malignancies. Although altered TRAF6 expression is observed in human acute myeloid leukemia (AML),...
4.
Muto T
Rinsho Ketsueki
. 2023 Oct;
64(9):962-969.
PMID: 37793872
Myeloid malignancies are composed of multiple clonal hematopoietic disorders, including myelodysplastic syndrome, myeloproliferative neoplasms, and acute myeloid leukemia. Inflammation is already known to play an important role in the pathogenesis...
5.
Muto T, Walker C, Agarwal P, Vick E, Sampson A, Choi K, et al.
Haematologica
. 2023 Apr;
108(10):2715-2729.
PMID: 37102608
Inflammation is associated with the pathogenesis of myelodysplastic syndromes (MDS) and emerging evidence suggests that MDS hematopoietic stem and progenitor cells (HSPC) exhibit an altered response to inflammation. Deletion of...
6.
Shibamiya A, Miyamoto-Nagai Y, Koide S, Oshima M, Rizq O, Aoyama K, et al.
Cancer Immunol Immunother
. 2023 Apr;
72(8):2635-2648.
PMID: 37069353
Dysfunctional anti-tumor immunity has been implicated in the pathogenesis of mature B cell neoplasms, such as multiple myeloma and B cell lymphoma; however, the impact of exhausted T cells on...
7.
Isshiki Y, Oshima M, Mimura N, Kayamori K, Miyamoto-Nagai Y, Seki M, et al.
JCI Insight
. 2022 Sep;
7(20).
PMID: 36129760
POEMS syndrome is a rare monoclonal plasma cell disorder, with unique symptoms distinct from those of other plasma cell neoplasms, including high serum VEGF levels. Because the prospective isolation of...
8.
Barreyro L, Sampson A, Ishikawa C, Hueneman K, Choi K, Pujato M, et al.
Sci Transl Med
. 2022 Mar;
14(635):eabb7695.
PMID: 35263148
Dysregulation of innate immune signaling pathways is implicated in various hematologic malignancies. However, these pathways have not been systematically examined in acute myeloid leukemia (AML). We report that AML hematopoietic...
9.
Muto T, Guillamot M, Yeung J, Fang J, Bennett J, Nadorp B, et al.
Cell Stem Cell
. 2022 Jan;
29(2):298-314.e9.
PMID: 35045331
Clonal hematopoiesis (CH) is an aging-associated condition characterized by the clonal outgrowth of pre-leukemic cells that acquire specific mutations. Although individuals with CH are healthy, they are at an increased...
10.
Ishii A, Tsukamoto S, Mishina T, Izumi S, Nagai Y, Yamazaki M, et al.
Leuk Res Rep
. 2021 Nov;
16:100278.
PMID: 34765438
A 45-year-old woman was diagnosed with myelodysplastic syndrome (MDS) with trisomy 8 and Behçet-like disease (BLD) with multiple colorectal ulcers. Nonspecific inflammatory cells were infiltrated in the intestinal mucosa, whereas...